André Pèlegrin
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 2%
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 62
- Radiopharmaceutical Chemistry and Applications 42
- Oncology 58
- HER2/EGFR in Cancer Research 26
- Co-authors
- Éric Vivès (5 shared papers)Julien Schmidt (2 shared papers)D. Azria (33 shared papers)Isabelle Navarro‐Teulon (23 shared papers)Christel Larbouret (32 shared papers)Jean‐Pierre Pouget (14 shared papers)Bruno Robert (31 shared papers)Thierry Chardès (26 shared papers)
- Journals
- British Journal of Cancer (10 papers)International Journal of Cancer (9 papers)Clinical Cancer Research (6 papers)mAbs (6 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
André Pèlegrin
147 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 112
- Radiology, Nuclear Medicine and Imaging 1.9k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 866
- Immunology 591
- Biotechnology 221
Countries citing papers authored by André Pèlegrin
This map shows the geographic impact of André Pèlegrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Pèlegrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Pèlegrin more than expected).
Fields of papers citing papers by André Pèlegrin
This network shows the impact of papers produced by André Pèlegrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Pèlegrin. The network helps show where André Pèlegrin may publish in the future.
Co-authors
The 25 scholars most cited alongside André Pèlegrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 389 | |
| 2 | 2011 | 195 | |
| 3 | 2018 | 119 | |
| 4 | 2008 | 115 | |
| 5 | 2010 | 115 | |
| 6 | Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. | 1994 | 112 |
| 7 | 2008 | 110 | |
| 8 | 2005 | 106 | |
| 9 | 1993 | 99 | |
| 10 | Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. | 1990 | 91 |
| 11 | 2016 | 90 | |
| 12 | 1992 | 88 | |
| 13 | 2017 | 85 | |
| 14 | 2013 | 84 | |
| 15 | 2004 | 79 | |
| 16 | 2001 | 72 | |
| 17 | 2010 | 70 | |
| 18 | 2007 | 69 | |
| 19 | 1991 | 69 | |
| 20 | 2011 | 64 |
About André Pèlegrin
André Pèlegrin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 150 papers that have together received 4.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (62 papers), Radiopharmaceutical Chemistry and Applications (42 papers), HER2/EGFR in Cancer Research (26 papers), Glycosylation and Glycoproteins Research (19 papers), Cancer Research and Treatments (11 papers), Nanoplatforms for cancer theranostics (10 papers), Neuroendocrine Tumor Research Advances (9 papers) and Photodynamic Therapy Research Studies (8 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.9k citations), Oncology (1.4k citations), Pulmonary and Respiratory Medicine (866 citations), Immunology (591 citations) and Biotechnology (221 citations). André Pèlegrin has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Éric Vivès, Julien Schmidt, D. Azria, Isabelle Navarro‐Teulon, Christel Larbouret, Jean‐Pierre Pouget, Bruno Robert, Thierry Chardès, Jean‐Pierre Mach and Silvio Folli. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, Clinical Cancer Research, mAbs and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.